This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2009 Feb;7(1):1-3.

doi: 10.1586/14787210.7.1.1.

hVISA/VISA: diagnostic and therapeutic problems

PMID: 19622051
DOI: 10.1586/14787210.7.1.1

Free article

Review

hVISA/VISA: diagnostic and therapeutic problems

Judit Szabó. Expert Rev Anti Infect Ther. 2009 Feb.

Free article

. 2009 Feb;7(1):1-3.

doi: 10.1586/14787210.7.1.1.

Author

PMID: 19622051
DOI: 10.1586/14787210.7.1.1

No abstract available

PubMed Disclaimer

Similar articles

Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure.
Kelley PG, Gao W, Ward PB, Howden BP. Kelley PG, et al. J Antimicrob Chemother. 2011 May;66(5):1057-60. doi: 10.1093/jac/dkr066. Epub 2011 Mar 2. J Antimicrob Chemother. 2011. PMID: 21393156
VraR Binding to the Promoter Region of agr Inhibits Its Function in Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA.
Dai Y, Chang W, Zhao C, Peng J, Xu L, Lu H, Zhou S, Ma X. Dai Y, et al. Antimicrob Agents Chemother. 2017 Apr 24;61(5):e02740-16. doi: 10.1128/AAC.02740-16. Print 2017 May. Antimicrob Agents Chemother. 2017. PMID: 28289032 Free PMC article.
Key considerations in the treatment of complicated staphylococcal infections.
Jones RN. Jones RN. Clin Microbiol Infect. 2008 Mar;14 Suppl 2:3-9. doi: 10.1111/j.1469-0691.2008.01923.x. Clin Microbiol Infect. 2008. PMID: 18226084 Review.
Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.
Sakoulas G, Moellering RC Jr, Eliopoulos GM. Sakoulas G, et al. Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S40-50. doi: 10.1086/491713. Clin Infect Dis. 2006. PMID: 16323119 Review.
Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogenous VISA (hVISA).
Howden BP. Howden BP. Intern Med J. 2005 Dec;35 Suppl 2:S136-40. doi: 10.1111/j.1444-0903.2005.00986.x. Intern Med J. 2005. PMID: 16271057 Review.

See all similar articles

Cited by

In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolates.
Leuthner KD, Vidaillac C, Cheung CM, Rybak MJ. Leuthner KD, et al. Antimicrob Agents Chemother. 2010 Sep;54(9):3799-803. doi: 10.1128/AAC.00452-10. Epub 2010 Jun 28. Antimicrob Agents Chemother. 2010. PMID: 20585126 Free PMC article.
Vancomycin heteroresistance in Staphylococcus haemolyticus: elusive phenotype.
Bathavatchalam YD, Solaimalai D, Amladi A, Dwarakanathan HT, Anandan S, Veeraraghavan B. Bathavatchalam YD, et al. Future Sci OA. 2021 Apr 9;7(7):FSO710. doi: 10.2144/fsoa-2020-0179. eCollection 2021 Aug. Future Sci OA. 2021. PMID: 34258023 Free PMC article.
The Continuing Threat of Methicillin-Resistant Staphylococcus aureus.
Gajdács M. Gajdács M. Antibiotics (Basel). 2019 May 2;8(2):52. doi: 10.3390/antibiotics8020052. Antibiotics (Basel). 2019. PMID: 31052511 Free PMC article. Review.
Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates.
Pitz AM, Yu F, Hermsen ED, Rupp ME, Fey PD, Olsen KM. Pitz AM, et al. J Clin Microbiol. 2011 Jan;49(1):269-74. doi: 10.1128/JCM.00914-10. Epub 2010 Oct 20. J Clin Microbiol. 2011. PMID: 20962147 Free PMC article.
The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA-Salvaging the Gold Standards with Combination Therapy.
Morrisette T, Alosaimy S, Abdul-Mutakabbir JC, Kebriaei R, Rybak MJ. Morrisette T, et al. Antibiotics (Basel). 2020 Oct 30;9(11):762. doi: 10.3390/antibiotics9110762. Antibiotics (Basel). 2020. PMID: 33143290 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal